U.S. Logistics Stock News

NYSE:AMRC
NYSE:AMRCConstruction

Is It Time To Reassess Ameresco (AMRC) After Its Recent Share Price Pullback?

If you are wondering whether Ameresco's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. Ameresco's stock has pulled back recently, with returns of a 3.9% decline over 7 days, a 26.7% decline over 30 days and a 19.4% decline year to date, even though the 1-year return sits at 134.4%, while 3-year and 5-year returns are a 42.7% decline and a 43.9% decline respectively. Recent news coverage around...
NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Assessing Navan (NAVN) Valuation After Recent Share Price Weakness And AI Growth Expectations

Navan (NAVN) has been drawing attention after a sharp pullback, with the stock down about 20% over the past month and close to 39% over the past 3 months. See our latest analysis for Navan. The recent weakness, including a 7.69% 1 day share price return and a 45.35% year to date share price return, suggests momentum has been fading despite interest in Navan's AI powered travel and expense platform and its latest close at $8.88. If sharp moves in a single name feel uncomfortable, you can...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Valuation Check After Sharp Multi‑Month Share Price Rebound

Moderna (MRNA) has been back on many investors’ screens after a sharp move in recent months, with the stock up about 30% over the past month and roughly 78% in the past 3 months. See our latest analysis for Moderna. While the share price has eased slightly over the last day, Moderna’s recent 30-day share price return of about 30% and year to date gain of roughly 70% point to building momentum, even as the 3 and 5 year total shareholder returns remain deeply negative. If Moderna’s recent...
NYSE:NVST
NYSE:NVSTMedical Equipment

Has Envista Holdings (NVST) Pulled Back Too Far After Recent Share Price Weakness?

If you are wondering whether Envista Holdings is attractively priced right now, this article will walk through what the current share price might be implying about its value. The stock last closed at US$25.44, with a 56.6% return over the past year, a 17.3% gain year to date, but declines of 8.9% over 7 days and 15.7% over 30 days that may have shifted how investors think about its risk and reward. Recent news flow around Envista has focused on its position in the healthcare space and how...
NYSE:AAP
NYSE:AAPSpecialty Retail

A Look At Advance Auto Parts (AAP) Valuation As Turnaround Progress Restores Profitability

Advance Auto Parts (AAP) is back on investors’ radar after management reported a return to positive comparable sales and operating income profitability, following extensive turnaround work across its supply chain, merchandising, and store operations. See our latest analysis for Advance Auto Parts. The recent turnaround update and conference commentary come after a volatile few years. The share price is at US$52.66 with a 90 day share price return of 13.56% and a 1 year total shareholder...
NasdaqGM:HLMN
NasdaqGM:HLMNMachinery

How Investors Are Reacting To Hillman Solutions (HLMN) Earnings Miss And Cautious Full-Year Outlook

Hillman Solutions recently reported a softer quarter, with revenue growing 4.5% year on year but falling short of analyst expectations and issuing full-year revenue guidance that also trailed consensus. Despite lifting its full-year outlook more than peers, Hillman’s results were viewed unfavorably, highlighting how even incremental misses against expectations can weigh on sentiment around its professional tools and hardware business. Next, we’ll examine how this earnings miss and cautious...
NasdaqGS:IRDM
NasdaqGS:IRDMTelecom

Does Iridium (IRDM) Dividend Stability Reflect Strategic Confidence or Limited Reinvestment Ambition?

Iridium Communications Inc. has affirmed a quarterly dividend of US$0.1500 per share, payable on March 31, 2026, to shareholders of record and ex-dividend on March 16, 2026. This dividend affirmation, following a quarter where earnings per share exceeded analyst expectations despite flat revenue, underscores management’s commitment to ongoing cash returns. We’ll now examine how the sustained dividend alongside better-than-expected earnings shapes Iridium’s investment narrative and future...
NYSE:IR
NYSE:IRMachinery

Assessing Ingersoll Rand (IR) Valuation After Recent Share Price Weakness

What recent performance says about Ingersoll Rand (IR) Ingersoll Rand (IR) has recently seen mixed share performance, with a 4.7% decline over the past day, a 10.3% decline over the past week, and a 17.0% decline over the past month. Even with that pressure, the stock shows a small 0.7% decline over the past 3 months. Longer windows are positive, including a 1.8% total return over the past year and higher multi year returns. See our latest analysis for Ingersoll Rand. Recent selling pressure...
NYSE:IONQ
NYSE:IONQTech

IonQ Links RoNaQCI Deployment With SkyWater Deal And Security Focus

IonQ (NYSE:IONQ) is providing quantum key distribution technology for Romania’s National Quantum Communication Infrastructure, RoNaQCI, aimed at securing critical European communications. The company announced a US$1.8b acquisition of SkyWater Technology, creating what it describes as the industry's first vertically integrated quantum company. These developments expand IonQ’s role in European secure communications and bring chip manufacturing capabilities in house. IonQ, a pure play quantum...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Assessing Micron Technology (MU) Valuation As AI Memory Demand And Partnerships Drive A Strong Cycle

Micron Technology (MU) is back in focus after Applied Materials announced a collaboration to co develop next generation DRAM, high bandwidth memory and NAND, aimed at more energy efficient AI systems. See our latest analysis for Micron Technology. Despite a 3.2% one day share price decline to US$405.35 during a broader tech pullback, Micron’s recent news flow around AI memory partnerships, product launches, and capacity expansions lines up with strong momentum, reflected in an 8.6% 30 day...
NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

Could AIRO Group Holdings' Drone Focus and Vertical Integration Redefine Its Defense Narrative (AIRO)?

On March 11, 2026, AIRO Group Holdings, Inc. presented at the Cantor Global Technology & Industrial Growth Conference in New York, with Executive Chairman Chirinjeev Kathuria, CEO Joe Burns, and CFO Mariya Pylypiv outlining the company’s integrated aerospace and defense offering. The focus on defense-oriented drones, proprietary technology and vertically integrated manufacturing, together with R&D and government certifications, underscored AIRO’s effort to build recurring revenue across...
NasdaqGS:ICUI
NasdaqGS:ICUIMedical Equipment

ICU Medical Confronts Revenue Strain As Valuation Signals Potential Upside

ICU Medical, NasdaqGS:ICUI, is dealing with ongoing revenue stagnation and rising capital intensity that point to operational and market pressures. Future sales are projected to decline, alongside shrinking free cash flow margins, highlighting concerns about the company’s ability to convert revenue into cash. These developments are emerging as fresh issues for investors and other stakeholders who follow ICU Medical’s financial and competitive position. ICU Medical’s current share price of...
NYSE:CL
NYSE:CLHousehold Products

Colgate-Palmolive Adds Healthcare CEO To Board And Extends Dividend Streak

Colgate-Palmolive (NYSE:CL) appointed Christopher Boerner, CEO of Bristol-Myers Squibb, to its Board of Directors. Board member Steven Cahillane will not stand for reelection at the company’s upcoming annual meeting. The company also announced its 62nd consecutive annual dividend increase. Colgate-Palmolive, the global consumer products company behind oral care, personal care, and home care brands, is adding a senior healthcare executive to its board at a time when cross-industry expertise...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Is It Time To Reassess Akamai Technologies (AKAM) After Its Strong Share Price Run?

If you are wondering whether Akamai Technologies is fairly priced or if the recent buzz has left it mispriced, you are in the right place for a closer look at what the current share price might be implying. Akamai's share price closed at US$105.47, with returns of 4.4% over 7 days, 11.7% over 30 days, 23.9% year to date, 34.1% over 1 year and 45.4% over 3 years, while the 5 year return stands at 7.4%. These price moves sit against an ongoing focus on Akamai's role in content delivery and...
NYSE:USFD
NYSE:USFDConsumer Retailing

Is It Too Late To Consider US Foods Holding (USFD) After Its Strong Multi Year Rally?

If you have been wondering whether US Foods Holding is still reasonably priced after its recent run, this article walks through what the numbers actually say about its current value. The stock last closed at US$92.61, with returns of 0.5% over 7 days, 2.1% over 30 days, 24.1% year to date and 45.4% over the past year, while the 3 year and 5 year returns sit at 167.8% and 151.3% respectively. Recent attention on US Foods has been driven by ongoing interest in large foodservice distributors...
NasdaqGS:CRVL
NasdaqGS:CRVLHealthcare

Is CorVel’s (CRVL) Debt-Free Strength a Hidden Edge in Claims Management or Just Prudence?

Recent analysis highlighted that CorVel passed a high-quality investment screen, underpinned by very large returns on invested capital and a debt-free balance sheet in its cost containment and claims management business. This focus on financial strength and operational resilience has drawn attention from investors who prioritize durable business models and conservative balance sheets. Next, we’ll examine how CorVel’s debt-free position shapes its investment narrative in light of the latest...
NYSE:MRK
NYSE:MRKPharmaceuticals

A Look At Merck (MRK) Valuation As Recent Gains Contrast Conflicting Fair Value Estimates

Merck (MRK) is back on investors’ radar after recent trading left the shares around $115.91, with short term returns mixed, while the past 3 months and year have shown stronger overall performance metrics. See our latest analysis for Merck. Short term share price returns for Merck have been soft, but a 15.56% 90 day share price return and 26.99% 1 year total shareholder return suggest momentum has recently been building for long term holders. If Merck’s moves have you reassessing healthcare,...
NYSE:CNK
NYSE:CNKEntertainment

Cinemark Holdings (CNK) Valuation Check After Recent Share Price Pullback And Multi Year Gain

Cinemark Holdings (CNK) shares have been relatively steady recently, with a one-month return near flat and a gain of about 4% over the past three months, prompting investors to reassess the cinema operator’s current valuation and earnings profile. See our latest analysis for Cinemark Holdings. At a share price of US$25.53, Cinemark’s recent moves include a 9.63% 7 day share price pullback alongside an 8.50% year to date share price return and a 3 year total shareholder return above 100%. This...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Assessing CareTrust REIT (CTRE) Valuation After Its Higher Dividend And Growth Confidence

CareTrust REIT (CTRE) is drawing fresh attention after its Board of Directors approved a higher quarterly common stock cash dividend, increasing the payout from $0.335 to $0.39 per share. See our latest analysis for CareTrust REIT. The higher dividend comes after a strong run in the shares, with a 90 day share price return of 10.47% and a 1 year total shareholder return of 50.87%, indicating momentum that long term holders have already experienced. If this dividend move has you looking beyond...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Assessing Photronics (PLAB) Valuation As AI Photomask Strength Meets Softer Demand And Margin Pressure

Recent commentary around Photronics (PLAB) is being driven by a mix of positives, including record revenue from high-end photomasks and fresh investments in U.S. and South Korean facilities, alongside softer demand, declining sales, and margin pressures. See our latest analysis for Photronics. Despite recent headlines around record high end photomask revenue and new capacity investments, Photronics’ recent share price performance has cooled. The company has a 30 day share price return of...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Is Robinhood Markets (HOOD) Still Attractive After 7x Gain And Recent Pullback

If you are wondering whether Robinhood Markets at around US$76 per share is priced for perfection or still has room based on fundamentals, you are not alone. The stock has pulled back recently, with a 5.5% decline over the last 7 days and an 11.1% decline over the last 30 days. However, the 1 year return sits at 111.3% and the 3 year gain is very large at around 7x. That swing in sentiment comes as Robinhood stays in the headlines for its role as a major retail trading platform and for...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Assessing Wave Life Sciences (WVE) Valuation After WVE-007 Obesity Data And Cash Runway Update

Wave Life Sciences (WVE) drew investor attention after reporting interim Phase I data for its INHBE obesity candidate WVE-007, and detailing a cash position it expects to fund multiple trials and regulatory milestones through 2026. See our latest analysis for Wave Life Sciences. The latest WVE-007 readout and funding runway arrive after a 1-year total shareholder return of about 30% and a very large 3-year total shareholder return, even as the 90-day share price return of a 19.38% decline and...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

Playtika Leadership Shakeup Puts Capital Allocation And Governance In Focus

Playtika Holding (NasdaqGS:PLTK) announced that Chief Financial Officer and President Craig Abrahams will resign effective April 1, 2026. Tae Lee, who has corporate finance experience at Playtika and Meta, will become acting CFO when the change takes effect. Board Chairperson Robert Antokol will also assume the role of President, taking on an expanded leadership position. Playtika operates in the mobile gaming sector, where user engagement, live operations and content updates tend to matter...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Sunrun (RUN) Valuation Check After Recent Volatility And A 37.3% Undervaluation Narrative

Sunrun (RUN) is back on investors’ radar after recent trading has highlighted how volatile the stock can be, with sharp swings over the past month and past 3 months drawing fresh scrutiny. See our latest analysis for Sunrun. At a share price of US$11.97, Sunrun’s recent 30 day and year to date share price returns of 42.06% and 38.43% declines sit in contrast with a 1 year total shareholder return of 92.75%. This suggests that earlier optimism has cooled while longer term holders still sit on...